They found that increased expression of RECQL1 was significantly associated with reduced relapse-free survival and post-progression survival in all breast cancers but improved overall survival in patients with basal-like breast cancer and mutant-p53-type breast cancer (Wang et al., 2009). Here, TP53 is linked to breast cancer.